Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2026-06-04 18:10:15 ET · period of report 2026-06-02 · accession 0001628280-26-040922 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-04 18:10 | 2026-06-02 | BMRN | Countouriotis Athena | Dir | A - Grant | $0.00 | +7,490 | 21.0K | +55% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-02 | A | A | 7,490 | $0.00 | 21,040 | D | — | — | (F1) Restricted stock units granted on June 2, 2026. Price not applicable. |